Fasentin diminishes endothelial cell proliferation, differentiation and invasion in a glucose metabolism-independent manner

The synthetic compound fasentin has been described as a modulator of GLUT-1 and GLUT-4 transporters, thus inhibiting glucose uptake in some cancer cells. Endothelial glucose metabolism has been recently connected to angiogenesis and it is now an emerging topic in scientific research. Indeed, certain...

Descripción completa

Detalles Bibliográficos
Autores principales: Ocaña, Mª Carmen, Martínez-Poveda, Beatriz, Marí-Beffa, Manuel, Quesada, Ana R., Medina, Miguel Ángel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7145862/
https://www.ncbi.nlm.nih.gov/pubmed/32273578
http://dx.doi.org/10.1038/s41598-020-63232-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7145862/
https://www.ncbi.nlm.nih.gov/pubmed/32273578
http://dx.doi.org/10.1038/s41598-020-63232-z

Ejemplares similares